[
    [
        {
            "time": "",
            "orginal_text": "医药生物行业：四季度常规诊疗继续恢复 板块业绩增速提升",
            "features": {
                "keywords": [
                    "医药生物",
                    "四季度",
                    "常规诊疗",
                    "恢复",
                    "板块业绩",
                    "增速提升"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业：四季度常规诊疗继续恢复 板块业绩增速提升",
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]